Drug Shortage Report for ATORVASTATIN
| Report ID | 236988 |
| Drug Identification Number | 02348721 |
| Brand name | ATORVASTATIN |
| Common or Proper name | ATORVASTATIN |
| Company Name | SANIS HEALTH INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ATORVASTATIN |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 500 |
| ATC code | C10AA |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-10-25 |
| Actual start date | 2024-10-23 |
| Estimated end date | 2025-04-25 |
| Actual end date | 2025-04-24 |
| Shortage status | Resolved |
| Updated date | 2025-04-25 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v15 | 2025-04-25 | English | Compare |
| v14 | 2025-04-24 | French | Compare |
| v13 | 2025-04-24 | English | Compare |
| v12 | 2025-03-26 | French | Compare |
| v11 | 2025-03-26 | English | Compare |
| v10 | 2025-03-26 | English | Compare |
| v9 | 2024-10-24 | English | Compare |
| v8 | 2024-10-23 | French | Compare |
| v7 | 2024-10-23 | English | Compare |
| v6 | 2024-10-10 | French | Compare |
| v5 | 2024-10-10 | English | Compare |
| v4 | 2024-10-09 | French | Compare |
| v3 | 2024-10-09 | English | Compare |
| v2 | 2024-09-09 | French | Compare |
| v1 | 2024-09-09 | English | Compare |
Showing 1 to 15 of 15